Literature DB >> 19269904

Determination of tolterodine and its 5-hydroxymethyl metabolite in human plasma by hydrophilic interaction liquid chromatography-tandem mass spectrometry.

Jan Macek1, Pavel Ptácek, Josef Klíma.   

Abstract

A rapid and reliable method was developed to quantitate tolterodine and its 5-hydroxymethyl metabolite in human plasma using liquid chromatography-electrospray tandem mass spectrometry. The assay was based on liquid-liquid extraction of the compounds from plasma with tert-butylmethylether and hydrophilic interaction chromatography performed on a silica column (30mmx4.6mm, 3microm particles), the mobile phase consisted of acetonitrile-20mM ammonium acetate (70:30, v/v). Quantification was through positive-ion mode and selected reaction monitoring at m/z 326-->147 for tolterodine, 342-->223 for the 5-hydroxymethyl metabolite and 260-->183 for the internal standard propranolol, respectively. The lower limit of quantitation was 49 and 46pg/ml using 0.5ml of plasma for the parent drug and its metabolite, respectively and linearity was observed up to 30ng/ml. Within-day and between-day precision expressed by relative standard deviation was less than 11% and inaccuracy did not exceed 7% at all levels. The assay was applied to the analysis of samples from a pharmacokinetic study.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19269904     DOI: 10.1016/j.jchromb.2009.02.036

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  2 in total

1.  A validated LC-MS/MS method for the determination of tolterodine and its metabolite in rat plasma and application to pharmacokinetic study.

Authors:  Rihana Parveen Shaik; Srinivasa Babu Puttagunta; Chandrasekhar Bannoth Kothapalli; Bahlul Zayed Sh Awen; B R Challa
Journal:  J Pharm Anal       Date:  2013-05-24

2.  Phosphorylation of JIP4 at S730 Presents Antiviral Properties against Influenza A Virus Infection.

Authors:  Juliana Del Sarto; Vanessa Gerlt; Yvonne Boergeling; Stephan Ludwig; Marcel Edgar Friedrich; Darisuren Anhlan; Viktor Wixler; Mauro Martins Teixeira
Journal:  J Virol       Date:  2021-07-28       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.